Showing items 401–500
Polyconjugates for delivery of RNAi triggers to tumor cells in vivo
Grant US-9487556-B2
United States of America
Epithelial membrane protein-2 (EMP2) and proliferative vitroretinopathy (PVR)
Grant US-9464135-B2
United States of America
Methods and compositions for the specific inhibition of gene expression by double-stranded…
Grant US-9441227-B2
United States of America
RNA interference for the treatment of gain-of-function disorders
Grant US-9434943-B2
United States of America
Protein surface remodeling
Grant US-9434774-B2
United States of America
Compositions and methods for silencing apolipoprotein C-III expression
Grant US-9428751-B2
United States of America
Methods and compositions for weed control
Grant US-9422558-B2
United States of America
Methods and compositions for weed control
Grant US-9422557-B2
United States of America
GENETIC POLYMORPHISMS ASSOCIATED WITH STATIN RESPONSE AND CARDIOVASCULAR DISEASES…
Application EP-3056899-A1
European Patent Office
Methods and compositions for weed control
Grant US-9416363-B2
United States of America
Antibody to GDF8 and uses thereof
Grant US-9409981-B2
United States of America
Antisense modulation of PTP1B expression
Grant US-9404113-B2
United States of America
Antisense modulation of GCGR expression
Grant US-9404114-B2
United States of America
GENETIC POLYMORPHISM ASSOCIATED WITH STROKE, THERAPY BASED ON THE DETECTION OF THE…
Application EP-3048175-A1
European Patent Office
Modulation of transthyretin expression
Grant US-9399774-B2
United States of America
Compositions and methods for modulating angiopoietin-like 3 expression
Grant US-9382540-B2
United States of America
FKBP-L and uses thereof
Grant US-9381228-B2
United States of America
Modulation of growth hormone receptor expression and insulin-like growth factor expression
Grant US-9371530-B2
United States of America
Modulation of apolipoprotein C-III expression
Grant US-9365848-B2
United States of America
Methods and compositions for the specific inhibition of gene expression by double-stranded…
Grant US-9365849-B2
United States of America
Modulation of signal transducer and activator of transcription 3 (STAT3) expression
Grant US-9359608-B2
United States of America
Compositions and their uses directed to huntingtin
Application US-9353372-B2
United States of America
Administering antisense oligonucleotides complementary to human apolipoprotein B
Grant US-9347061-B2
United States of America
Methods and compositions for modulating alpha-1-antitrypsin expression
Grant US-9340784-B2
United States of America
Selective inhibition of polyglutamine protein expression
Application US-9340785-B2
United States of America
Methods for modulating kallikrein (KLKB1) expression
Grant US-9322021-B2
United States of America
Tissue culture method for producing cartilage using trimethylamine N-oxide and…
Application US-9321993-B2
United States of America
Methods for modulating kallikrein (KLKB1) expression
Grant US-9315811-B2
United States of America
Phased small RNAs
Grant US-9309512-B2
United States of America
Small activating RNA molecules and methods of use
Grant US-9297008-B2
United States of America
RNAi sequence-independent modification formats, and stabilized forms thereof
Grant US-9284551-B2
United States of America
Photobioreactor
Grant US-9284519-B2
United States of America
SiRNA sequence-independent modification formats for reducing off-target phenotypic…
Grant US-9273312-B2
United States of America
Modulation of huntingtin expression
Application US-9273315-B2
United States of America
Compositions and methods for inhibiting expression of the PCSK9 gene
Grant US-9260718-B2
United States of America
Plants having increased desiccation tolerance, increased drought tolerance or increased…
Grant US-9243261-B2
United States of America
Conjugated lipomers and uses thereof
Grant US-9238716-B2
United States of America
Methods and compositions for selecting siRNA of improved functionality
Grant US-9228186-B2
United States of America
Methods and DNA constructs for autoregulating transgene silencing
Application US-9222100-B2
United States of America
Supercharged proteins for cell penetration
Grant US-9221886-B2
United States of America
Versatile nucleic acid hairpin motif for programming biomolecular self-assembly pathways
Grant US-9217151-B2
United States of America
Recombinant DNA constructs and methods for controlling gene expression
Grant US-9212370-B2
United States of America
METHOD OF SEQUENCING AND IDENTIFYING RNAs
Application WO-2015181397-A1
World Intellectual Property Organisation (WIPO)
Poly(beta-amino alcohols), their preparation, and uses thereof
Grant US-9193827-B2
United States of America
METHOD FOR OPENING TIGHT JUNCTIONS
Application EP-2944694-A1
European Patent Office
Methods for modulating factor 12 expression
Grant US-9187749-B2
United States of America
Compositions and methods for silencing ebola virus gene expression
Grant US-9187748-B2
United States of America
Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and…
Grant US-9176114-B2
United States of America
Modulation of androgen receptor expression
Grant US-9175291-B2
United States of America
Modulation of apolipoprotein CIII (ApoCIII) expression
Grant US-9157082-B2
United States of America
Methods for modulating factor 12 expression
Grant US-9150864-B2
United States of America
Protein surface remodeling
Grant US-9150626-B2
United States of America
Modulation of angiopoietin-like 3 expression
Grant US-9139831-B2
United States of America
Method and medicament for inhibiting the expression of a given gene
Grant US-9133454-B2
United States of America
Gene silencing by single-stranded polynucleotides
Grant US-9132148-B2
United States of America
Modulation of hepatitis B virus (HBV) expression
Grant US-9127278-B2
United States of America
Receptor-mediated delivery: compositions and methods
Grant US-9127293-B2
United States of America
Method for controlling herbicide-resistant plants
Grant US-9121022-B2
United States of America
Methods and compositions for enhancing the efficacy and specificity of RNA silencing
Grant US-9121018-B2
United States of America
Compositions and methods of targeting apolipoprotein B for the reduction of…
Grant US-9107933-B2
United States of America
Methods for diagnosis and treatment of endometrial cancer
Grant US-9110064-B2
United States of America
Modified siRNA molecules incorporating 5-fluoro-2′-deoxyuridine residues to enhance…
Grant US-9096853-B2
United States of America
Method for inhibiting bone resorption
Grant US-9089553-B2
United States of America
Modified siRNA molecules and uses thereof
Grant US-9074208-B2
United States of America
Modulation of transthyretin expression
Grant US-9061044-B2
United States of America
Compositions and their uses directed to huntingtin
Application US-9057066-B2
United States of America
Modulators of Itch ubiquitinase activity
Grant US-9051572-B2
United States of America
Short antisense compounds with gapmer configuration
Grant US-9045754-B2
United States of America
Modulation of hepatitis B virus (HBV) expression
Grant US-9034841-B2
United States of America
Antisense modulation of PTP1B expression
Grant US-9034842-B2
United States of America
Modulation of factor 7 expression
Grant US-9029337-B2
United States of America
Compositions and methods for silencing apolipoprotein C-III expression
Grant US-9023820-B2
United States of America
SIRNA AND THEIR USE IN METHODS AND COMPOSITIONS FOR INHIBITING THE EXPRESSION OF THE…
Application WO-2015059122-A2
World Intellectual Property Organisation (WIPO)
siRNA and their use in methods and compositions for inhibiting the expression of the…
Application EP-2865758-A1
European Patent Office
Methods of treating cancer by administering EMP2 antibodies
Grant US-9011857-B2
United States of America
Selective reduction of allelic variants
Grant US-9006198-B2
United States of America
Amine-containing lipids and uses thereof
Grant US-9006487-B2
United States of America
Recombinant DNA constructs and methods for controlling gene expression
Grant US-9000264-B2
United States of America
Antisense modulation of superoxide dismutase 1, soluble expression
Grant US-8993529-B2
United States of America
Compositions and methods for modulation of SMN2 splicing in a subject
Grant US-8980853-B2
United States of America
MicroRNAs
Grant US-8975471-B2
United States of America
Compounds and methods for modulating expression of DGAT2
Grant US-8969316-B2
United States of America
Aminoalcohol lipidoids and uses thereof
Grant US-8969353-B2
United States of America
PKR activation via hybridization chain reaction
Grant US-8962582-B2
United States of America
Triggered molecular geometry based bioimaging probes
Grant US-8962241-B2
United States of America
Selective reduction of allelic variants
Grant US-8957040-B2
United States of America
Compositions and their uses directed to huntingtin
Application US-8952145-B2
United States of America
Methods of treating chemoresistance and relapse in cancer cells
Grant US-8952028-B2
United States of America
Genetic variants for breast cancer risk assessment
Grant US-8951735-B2
United States of America
Compositions and methods for modulation of SMN2 splicing
Grant US-8946183-B2
United States of America
Compositions and methods for treatment of pouchitis
Grant US-8946178-B2
United States of America
Plant microRNAs and methods of use thereof
Grant US-8946511-B2
United States of America
Antisense modulation of fibroblast growth factor receptor 4 expression
Grant US-8933213-B2
United States of America
Methods for slowing familial ALS disease progression
Grant US-8921331-B2
United States of America
METHOD AND APPARATUS FOR CLOSE-FIELD ELECTROPORATION
Application WO-2014201511-A1
World Intellectual Property Organisation (WIPO)
Modulation of CD40 expression
Grant US-8916531-B2
United States of America
SNPs of apolipoprotein B and modulation of their expression
Grant US-8916694-B2
United States of America
Methods for treating hypercholesterolemia
Grant US-8912160-B2
United States of America
Modulation of huntingtin expression
Grant US-8906873-B2
United States of America
Showing items 401–500